Outset Medical(OM)
Focus: Outset Medical is a public medical device company focused on hemodialysis systems for end-stage renal disease (ESRD), competing in the specialized nephrology market. With $130M in FY2025 revenue, the company operates at mid-cap biotech scale with a concentrated product portfolio.
Profile data last refreshed 2h ago · AI intelligence enriched 2w ago
Funding Stage
PUBLIC
Open Jobs
25-2 this month
Stable — net -2 jobs in 30d
8 added, 10 removed. Backfill posture.
Should You Work at Outset Medical?
AI assessmentOutset is a specialized device play with strong R&D commitment and market focus, but pre-profitability status and concentrated portfolio create career execution risk.
Why Work Here
- High R&D intensity (44% of revenue) signals serious investment in innovation and product development roles
- Medical device focus in nephrology offers exposure to a specialized, high-need therapeutic area with limited competition
Data completeness
5/9 — Partial
Company HealthStrong
Pipeline
Early-stage
6 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Revenue
$130M
Key Products
Tablo Hemodialysis System
Growing
Growth
Core commercial product driving company revenue and subject of multiple clinical trial programs focused on dialysate flow rate optimization and intermittent therapy applications.
Pipeline & Clinical Trials
Help build intelligence for Outset Medical
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.